annual cash & cash equivalents:
$2.72B-$3.78B(-58.19%)Summary
- As of today (July 3, 2025), ROIV annual cash & cash equivalents is $2.72 billion, with the most recent change of -$3.78 billion (-58.19%) on March 1, 2025.
- During the last 3 years, ROIV annual cash & cash equivalents has risen by +$655.01 million (+31.79%).
- ROIV annual cash & cash equivalents is now -58.19% below its all-time high of $6.49 billion, reached on March 31, 2024.
Performance
ROIV Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.72B+$724.73M(+36.41%)Summary
- As of today (July 3, 2025), ROIV quarterly cash & cash equivalents is $2.72 billion, with the most recent change of +$724.73 million (+36.41%) on March 1, 2025.
- Over the past year, ROIV quarterly cash & cash equivalents has dropped by -$3.78 billion (-58.19%).
- ROIV quarterly cash & cash equivalents is now -59.29% below its all-time high of $6.67 billion, reached on December 31, 2023.
Performance
ROIV quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ROIV Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.2% | -58.2% |
| 3 y3 years | +31.8% | +31.8% |
| 5 y5 years | +32.1% | - |
ROIV Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.2% | +61.9% | -59.3% | +92.8% |
| 5 y | 5-year | -58.2% | +61.9% | -59.3% | +92.8% |
| alltime | all time | -58.2% | +61.9% | -59.3% | +92.8% |
ROIV Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $2.72B(-58.2%) | $2.72B(+36.4%) |
| Dec 2024 | - | $1.99B(+1.6%) |
| Sep 2024 | - | $1.96B(-65.5%) |
| Jun 2024 | - | $5.68B(-12.6%) |
| Mar 2024 | $6.49B(+287.3%) | $6.49B(-2.6%) |
| Dec 2023 | - | $6.67B(+373.7%) |
| Sep 2023 | - | $1.41B(-1.8%) |
| Jun 2023 | - | $1.43B(-14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $1.68B(-18.6%) | $1.68B(+9.8%) |
| Dec 2022 | - | $1.53B(-4.5%) |
| Sep 2022 | - | $1.60B(-17.7%) |
| Jun 2022 | - | $1.94B(-5.7%) |
| Mar 2022 | $2.06B(+0.3%) | $2.06B(-6.9%) |
| Dec 2021 | - | $2.21B(-11.3%) |
| Sep 2021 | - | $2.50B(+25.1%) |
| Jun 2021 | - | $2.00B(-2.8%) |
| Mar 2021 | $2.06B | $2.06B |
FAQ
- What is Roivant Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Roivant Sciences?
- What is Roivant Sciences annual cash & cash equivalents year-on-year change?
- What is Roivant Sciences quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Roivant Sciences?
- What is Roivant Sciences quarterly cash & cash equivalents year-on-year change?
What is Roivant Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ROIV is $2.72B
What is the all time high annual cash & cash equivalents for Roivant Sciences?
Roivant Sciences all-time high annual cash & cash equivalents is $6.49B
What is Roivant Sciences annual cash & cash equivalents year-on-year change?
Over the past year, ROIV annual cash & cash equivalents has changed by -$3.78B (-58.19%)
What is Roivant Sciences quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ROIV is $2.72B
What is the all time high quarterly cash & cash equivalents for Roivant Sciences?
Roivant Sciences all-time high quarterly cash & cash equivalents is $6.67B
What is Roivant Sciences quarterly cash & cash equivalents year-on-year change?
Over the past year, ROIV quarterly cash & cash equivalents has changed by -$3.78B (-58.19%)